Phase 2 Parkinson's Disease Trial, Recruiting NCT05700825 Sponsor: Teachers College, Columbia University Condition: Parkinson's Disease
Back to Parkinsons Disease

Phase 2 Parkinson's Disease Trial, Recruiting

NCT05700825
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Parkinson's disease at a moderate to fairly advanced stage, confirmed by a specialist neurologist who reviewed a standardized video assessment of your movement
  • You have trouble swallowing safely, meaning liquids may go toward your airway, or you have a weak cough that may not protect your lungs effectively (as measured by specific swallowing and cough tests)
  • You are not currently taking part in any exercise-based swallowing therapy
  • You are between 50 and 90 years old

Who may not be able to join:

  • You have another neurological condition such as multiple sclerosis, a history of stroke, or a brain tumor
  • You have a history of head or neck cancer
  • You have a history of breathing conditions such as COPD or other lung/airway diseases
  • You have smoked within the last five years
  • You have high blood pressure that is not well controlled by treatment
  • You have severe depression (scoring above 28 on a standard depression scale) or significant memory/thinking difficulties (scoring below 19 on a standard cognitive test)
  • You have an allergy to capsaicin (the compound that makes chili peppers hot) or barium (a substance used in some swallowing tests)
  • You live more than 1.5 hours away (door to door) from either Teachers College at Columbia University or Purdue University

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Michelle Troche, PhD, Teachers College, Columbia University

Phone: 212-678-3072

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Teachers College, Columbia University
Registry
ClinicalTrials.gov
Start date
11 August 2022
Est. completion
1 September 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Peak Expiratory Flow Rate (Cough PEFR) - phase 1; Change in Peak Expiratory Flow Rate (Cough PEFR) - phase 2; Change in Penetration-Aspiration Scale (PAS) - phase 1; Change in Penetration-Aspiration Scale (PAS) - phase 2

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov